SkinCure Oncology marks Skin Cancer Awareness Month, encouraging patients to have ‘voice and choice’ in their treatment

BURR RIDGE, Ill., May 3, 2022 /PRNewswire/ — May is Skin Cancer Awareness Month, and SkinCure Oncology has launched a campaign to encourage people with common skin cancers to learn about effective, evidence-based treatment options. evidence and to choose the treatment that suits them best. The company, which provides a comprehensive model for the delivery of image-guided superficial radiotherapy (image-guided SRT), the most advanced non-surgical technology for the treatment of basal and squamous cell carcinoma, believes that educated patients will play a more active role with their doctor in making critical healthcare decisions.

Some 3.3 million Americans are diagnosed with non-melanoma skin cancer each year, resulting in approximately 2,000 deaths. While physicians traditionally opted for Mohs surgery on most patients with these cancers, image-guided SRT is often preferred today. With Mohs, the surgeon uses a scalpel to remove suspicious tissue until microscopic examination of the tissue shows that all of the cancer is removed. But with image-guided SRT, which has a 99.3% effectiveness rate, there’s no surgery. Instead, low-intensity radiation, similar to X-rays, is directed at the cancer during a series of short office visits. Ultrasound imaging allows for more precise targeting of radiation and allows patients to actually see their cancer shrink and disappear. Unlike Mohs surgery, there are no cuts, bleeds, or surgical scars.

“Although surgery is indicated in some cases, it may have become the default prescription for these types of cancer, even though there are less invasive treatment options,” said Daniel Ladd, DO, FAOCD, FAAD and Medical Director of SkinCure Oncology. “If we really want an informed patient, who takes an active role in their health, we need to better give them access to the knowledge that will get them there, ensure they have a voice and a choice in their treatment.”

Anchored by a call for patients and their families to “Get skINFORMED” about treatment options, the SkinCure Oncology campaign includes literature, billboards, social media and an education website of patients, www.getskinformed.org.

Dr. Ladd noted that simple precautions can reduce the risk of skin cancer, such as using high SPF sunscreen, wearing protective clothing, minimizing sun exposure and avoidance of all indoor tanning devices.

“Given the relative ease of avoiding skin cancer and new patient-friendly treatment options, everyone should follow the golden rule – be sun-safe and have regular medical check-ups,” he said. he concluded.

About SkinCure Oncology
SkinCure Oncology is the world leader in providing a comprehensive model for the delivery of Image-Guided Superficial Radiation Therapy (Image-Guided SRT), the most advanced non-surgical technology for the treatment of skin cancers. common skin. The company partners with quality-focused Mohs dermatologists and surgeons to bring radiation therapy treatment from cancer centers to physicians’ offices. To date, SkinCure Oncology works with more than 200 dermatology practices nationwide, and more than 40,000 patients have been treated with image-guided SRT over the past five years. Learn more about the company at SkinCureOncology.com and visit GentleCure.com for helpful consumer and patient information.

Media Contact:
Matt RusselCEO
Russell Public Communications
520-232-9840
[email protected]

SOURCE SkinCure Oncology